Novartis acquires Vedere Bio to advance optogenetic gene therapy for vision restoration
In a significant acquisition that could reshape the landscape of gene therapy for vision restoration, Swiss pharmaceutical giant…
Lilly secures $375m deal with US govt for bamlanivimab Covid-19 treatment
Eli Lilly and Company (Lilly), a global pharmaceutical leader, has signed a significant $375 million agreement with the…
Exact Sciences to acquire Thrive Earlier Detection in landmark $2.15bn deal
In a move set to revolutionize cancer detection, Exact Sciences, a prominent US molecular diagnostics company, has announced…
Paramit to expand into Europe with acquisition of S.I.E. SOLUTIONS
In a strategic move to strengthen its global footprint, Paramit Corporation, a US-based leader in the design and…
Bayer to acquire Asklepios BioPharmaceutical in $4bn deal: A strategic move in gene therapy innovation
In a significant development within the pharmaceutical industry, German pharma giant Bayer has reached an agreement to acquire…
AstraZeneca resumes AZD1222 Covid-19 vaccine trials after safety review
AstraZeneca has announced the resumption of its clinical trials for the AZD1222 Covid-19 vaccine candidate in multiple countries,…
Precision Nanosystems secures C$18.2m funding for mRNA COVID-19 vaccine development
Precision Nanosystems (PNI), a Vancouver-based biotechnology company, has secured a significant funding boost of up to CAD 18.2…
Gilead Sciences completes $21bn acquisition of Immunomedics: A new era in cancer treatment
Gilead Sciences, a leading US-based pharmaceutical giant, has successfully concluded its $21 billion acquisition of Immunomedics, a New…
Remdesivir FDA approval: A milestone in the fight against COVID-19
In a significant development for the medical and pharmaceutical communities, Gilead Sciences, a California-based biopharmaceutical company, has received…
VelosBio initiates Phase 2 trial for ROR1-targeting antibody-drug conjugate VLS-101 in solid tumors
VelosBio, a San Diego-based biopharmaceutical company, has reached a significant milestone in the development of its investigational antibody-drug…